Explore our company news and media resources.

Contact us

Global Communications 
1000 Mylan Blvd. Canonsburg, PA 15317

+1. 724.514.1968

More info

May 10, 2021

Reports First Quarter 2021 Financial Results - Total Revenue of $4.4 billion, U.S. GAAP net loss of $1.0 billion, Adjusted EBITDA of $1.6 billion, U.S. GAAP net cash provided by operating...

May 6, 2021

Viatris Inc. (NASDAQ: VTRS), a new kind of healthcare company formed in November 2020, today released its inaugural sustainability report, reinforcing its strong foundation in corporate social...

Apr 30, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021. Chief...

Apr 29, 2021

Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Securities 2021 Health Care Conference on Tuesday, May 11, 2021. President Rajiv Malik...

Apr 28, 2021

Cost of the test will be reduced to improve access and stimulate demand in 135 low- and middle-income countries PITTSBURGH and SYDNEY, April 29, 2021 /PRNewswire/ -- Viatris Inc. and Atomo...

Browse press releases

Featured Stories

Helping to Increase Access to HIV Prevention

One of the most effective interventions in public health is Pre-Exposure Prophylaxis (PrEP) for HIV. To help address the need for more accessible options, Viatris is proud to offer a generic form of a PrEP treatment in the U.S. with the goal of expanding access for the at-risk population. 

Learn more

Featured News
Apr 7, 2021

At Viatris, we are reimagining healthcare not as it is, but as it should be.

Mar 1, 2021

Highlighting a strong foundation and clear roadmap for the future at our inaugural Investor Day, Viatris leaders showcased our journey to build a new kind of healthcare company.

Aug 5, 2020

As a leading healthcare company, Viatris is committed to doing its part in support of public health needs amid the evolving COVID-19 pandemic.

Browse articles

In the News
Nov 17, 2020
VIATRIS™ started trading today on Nasdaq, and Executive Chairman Robert J. Coury and CEO Michael Goettler shared their excitement during an interview at Nasdaq’s global Client Experience Center, located in the heart of Times Square in New York City.
Stay Connected